RIVASTIGMINA 9 MG ADES TRANSD CT ENV PAP/PLAS PET/AL/PAN X 7
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1057307710016 -
GGREM
552921120141606 -
Código de barras
7896658039188
O que a fonte publica
- Detentor do registro
- ACHÉ LABORATÓRIOS FARMACÊUTICOS S.A
- Princípios ativos
- RIVASTIGMINA
- Embalagem
- 9 MG ADES TRANSD CT ENV PAP/PLAS PET/AL/PAN X 7
- Regime de dispensação
- Tarja Vermelha sob restrição
- Tipo de produto
- Genérico
- Classe terapêutica
- N7D1 - PRODUTOS ANTIALZHEIMER, INIBIDORES DA COLINESTERASE
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "RIVASTIGMINA 9 MG ADES TRANSD CT ENV PAP/PLAS PET/AL/PAN X 7",
"holder": "ACHÉ LABORATÓRIOS FARMACÊUTICOS S.A",
"stripe": "Tarja Vermelha sob restrição",
"barcodes": [
"7896658039188"
],
"confaz87": true,
"currency": "BRL",
"marketed": null,
"ggremCode": "552921120141606",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "60.659.463/0029-92",
"priceRegime": "Regulado",
"productName": "RIVASTIGMINA",
"productType": "Genérico",
"hospitalOnly": false,
"presentation": "9 MG ADES TRANSD CT ENV PAP/PLAS PET/AL/PAN X 7",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha sob restrição",
"factoryPrices": {
"icms-0": "76.22",
"icms-12": "86.61",
"icms-17": "91.83",
"icms-18": "92.95",
"icms-19": "94.10",
"icms-20": "95.28",
"icms-21": "96.48",
"icms-22": "97.72",
"icms-23": "98.99",
"icms-17.5": "92.39",
"icms-19.5": "94.68",
"icms-20.5": "95.87",
"icms-22.5": "98.35",
"icms-12-alc": "85.57",
"icms-17-alc": "90.73",
"icms-18-alc": "91.84",
"icms-19-alc": "92.97",
"icms-20-alc": "94.13",
"icms-21-alc": "95.32",
"icms-22-alc": "96.55",
"icms-23-alc": "97.80",
"withoutTaxes": "75.31",
"icms-17.5-alc": "91.28",
"icms-19.5-alc": "93.55",
"icms-20.5-alc": "94.72",
"icms-22.5-alc": "97.17"
},
"pisCofinsList": "Positiva",
"substanceText": "RIVASTIGMINA",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "105.06",
"icms-12": "119.38",
"icms-17": "126.58",
"icms-18": "128.12",
"icms-19": "129.71",
"icms-20": "131.33",
"icms-21": "132.99",
"icms-22": "134.70",
"icms-23": "136.45",
"icms-17.5": "127.35",
"icms-19.5": "130.51",
"icms-20.5": "132.15",
"icms-22.5": "135.57",
"icms-12-alc": "118.30",
"icms-17-alc": "125.43",
"icms-18-alc": "126.96",
"icms-19-alc": "128.53",
"icms-20-alc": "130.13",
"icms-21-alc": "131.77",
"icms-22-alc": "133.47",
"icms-23-alc": "135.20",
"withoutTaxes": "104.11",
"icms-17.5-alc": "126.19",
"icms-19.5-alc": "129.33",
"icms-20.5-alc": "130.94",
"icms-22.5-alc": "134.33"
},
"invalidBarcodes": [],
"activeSubstances": [
"RIVASTIGMINA"
],
"therapeuticClass": "N7D1 - PRODUTOS ANTIALZHEIMER, INIBIDORES DA COLINESTERASE",
"commercialisation": {
"year": 2025,
"marketed": false
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1057307710016",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "N7D1",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:552921120141606"